Chromatin and Cancer: From Mechanisms to Emerging Therapies with Charles Roberts – AIEOP

AIEOP (Italian Association of Pediatric Hematology Oncology) shared a post by St. Jude Children’s Research Hospital on LinkedIn, adding:

”Next up from St. Jude Children’s Research Hospital’s The Science of Childhood Cancer Lecture Series.

Chromatin and Cancer: From Mechanisms to Emerging Therapies with Charles Roberts.

This Thursday, September 5 at 7pm CET.”

Quoting St. Jude Children’s Research Hospital’s post:

”Don’t miss the opportunity to gain insights into the mechanisms of cancer and emerging therapies for cancer treatment in our next The Science of Childhood Cancer virtual lecture on September 5th at 12PM CT/1PM ET.

Join us to hear Charles Roberts, St. Jude Executive Vice President, and Director of the Comprehensive Cancer Center, share groundbreaking insights into how mutations fuel cancer and discuss the latest advancements in targeted therapies that are paving the way for more effective treatments.

Register here.”

Source: AIEOP/LinkedIn and St. Jude Children’s Research Hospital/LinkedIn

Charles Roberts is the Cancer Center Director and Executive Vice President at St. Jude Children’s Research Hospital. He oversees research activities across basic laboratory, clinical, and population-based studies within the National Cancer Institute-designated Comprehensive Cancer Center. As an active physician-scientist, he leads a research laboratory focused on SWI/SNF, the most frequently mutated chromatin regulator in human cancer, and serves as an attending physician on the leukemia/lymphoma service.

St. Jude Children’s Research Hospital, founded in 1962 by Danny Thomas, is a nonprofit institution located in Memphis, Tennessee. Accredited as an NCI cancer center in 1977 and recognized as a comprehensive cancer center in 2008, its primary objective is to advance pediatric cancer cures through research and treatment.St. Jude is the only NCI-Designated Comprehensive Cancer Center dedicated solely to children. St. Jude integrates specialists and researchers across various disciplines into five collaborative research programs. Additionaly, St. Jude aims to make discoveries accessible globally and has developed protocols for pediatric cancer care, tailored for resource-limited settings, to save numerous children’s lives.